Addiction

Government of Canada signs two bilateral agreements with Quebec to support initiatives to improve health care

Retrieved on: 
Wednesday, March 27, 2024
Transfer, Create, MedlinePlus, Homelessness, Government, Shingles, Respite care, Mental, Caregiver, Federation, Patient, Conditional sentence, Dignity, Mental health, Addiction, Working Together, Hospital, Long-term care, CHT, Outline, Data collection, Social services, Investment, Indigenous peoples, Dashboard, Vaccination, Workforce, Disability, Geography, Parent, Health insurance

Today, the Honourable Mark Holland, Canada's Minister of Health, announced the signing of two bilateral agreements to invest more than $3.7 billion in federal funding to improve health care in Quebec.

Key Points: 
  • Today, the Honourable Mark Holland, Canada's Minister of Health, announced the signing of two bilateral agreements to invest more than $3.7 billion in federal funding to improve health care in Quebec.
  • The Government of Canada will initially provide $2.5 billion to support Quebec's Department of Health and Social Services' 2023-2027 strategic plan.
  • This will enable the sharing of best practices and ensure continuous improvement of the health care system.
  • This will improve the transparency of results, help manage public health emergencies, and ensure that individuals can access their own health information, which will be shared among health care workers in all health care settings.

NEDHSA inks MOUs with NELA Arts Council, NELA Music Awards to further recognize art as treatment strategy

Retrieved on: 
Tuesday, March 26, 2024
MOU, Culture, Organization, Health promotion, University, Environment, Music, Addiction, Partnership, Education, Mental health, Psychodrama, Economic development, Disability studies, Art, Hope, American Heritage Museum, ULM, Student, Dream, HSA, The arts, Medicine, Person

MONROE, La., March 26, 2024 /PRNewswire-PRWeb/ -- Northeast Delta Human Services Authority (NEDHSA) signed a Memorandum of Understanding with the Northeast Louisiana Arts Council (NELAAC) and the NELA Music Awards, respectively. Each respective MOU is an effort to recognize arts as one of its integrated health care, evidence-based prevention, communications, and treatment strategies to help serve persons with mental health, addictive disorders, and developmental disabilities.

Key Points: 
  • Northeast Delta Human Services Authority (NEDHSA) signed a Memorandum of Understanding with the Northeast Louisiana Arts Council (NELAAC) and the NELA Music Awards, respectively.
  • MONROE, La., March 26, 2024 /PRNewswire-PRWeb/ -- Northeast Delta Human Services Authority (NEDHSA) signed a Memorandum of Understanding with the Northeast Louisiana Arts Council (NELAAC) and the NELA Music Awards, respectively.
  • "We believe there is medicine in creative expression, and the arts can help a person come alive in ways traditional treatment options can't," Dr. Sizer said.
  • NELA Music Awards President Myra Akers said, "The NELA Music Awards is proud to partner with the Northeast Delta Human Services Authority."

Grants to promote healthy living for high school students across Canada

Retrieved on: 
Tuesday, March 26, 2024
School, Addiction, Mental health, Student, The Honourable, Environment, Tourism

Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced the first round of successful projects under the School Health Grant for Youth program.

Key Points: 
  • Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced the first round of successful projects under the School Health Grant for Youth program.
  • Grants of up to $3,500 are approved for 81 high school students across Canada to develop youth-driven and youth-inspired initiatives that encourage and promote healthy living in their schools.
  • The initiatives align with four health priorities: to reduce substance-related harms, foster positive mental health and well-being, promote healthy eating and nutrition, or encourage physical activity among their peers.
  • For more information on the program, and how to apply, go to the School Health Grant for Youth webpage .

Government of Canada Tables Final Report of the Legislative Review of the Cannabis Act

Retrieved on: 
Thursday, March 21, 2024
Addiction, First Nations, Mental health, Government, Crime, Face, Panel, Risk, Cannabis Act, Public, Law enforcement, The Honourable, Sale, Policy, Health Canada, Cannabis, Woman, Progress, Indigenous peoples, Safety, Legislation, Person, Drug

OTTAWA, ON, March 21, 2024 /CNW/ - In 2018, the Government of Canada introduced the Cannabis Act , which put into place a legal framework that takes a comprehensive public health approach to cannabis.

Key Points: 
  • OTTAWA, ON, March 21, 2024 /CNW/ - In 2018, the Government of Canada introduced the Cannabis Act , which put into place a legal framework that takes a comprehensive public health approach to cannabis.
  • In accordance with the Act, the Honourable Mark Holland, Minister of Health and the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health released the final report of the Legislative Review of the Cannabis Act.
  • This final report is the result of the extensive work conducted by the independent Expert Panel, chaired by Morris Rosenberg, that led the review over the last 18 months.
  • "I would like to thank Chair Rosenberg and the members of the Expert Panel for their enormous effort and dedication in leading the first-ever Legislative Review of the Cannabis Act.

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

Retrieved on: 
Saturday, March 2, 2024
Sale, Exercise, Regulation D, Form, Form S-1, Disorder, Act, Addiction, Security (finance)

The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No.

Key Points: 
  • The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No.
  • The gross proceeds to the Company from the exercise of the warrants are expected to be $3,530,500, prior to deducting placement agent fees and estimated offering expenses.
  • In consideration for the immediate exercise of the warrants for cash and the payment of $0.125 per new warrant, the Company will issue new unregistered warrants to purchase up to 2,300,000 shares of common stock.
  • The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants.

Cannabis Science Conference Spring 2024 announces new workshop powered by Cannabis Nurses Network™

Retrieved on: 
Friday, March 1, 2024
Shift, Knowledge, Nursing, Paradigm shift, Addiction, Future, Conference, CNN, Health, CSC, Harm reduction, Drug

CRANBURY, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation and compliance, is thrilled to announce its new and exciting full-day workshop for CSC Spring 2024.

Key Points: 
  • CRANBURY, N.J., March 01, 2024 (GLOBE NEWSWIRE) -- Cannabis Science Conference (CSC), the premier cannabis science conference focusing on analytical science, medical cannabis, cultivation and compliance, is thrilled to announce its new and exciting full-day workshop for CSC Spring 2024.
  • Powered by Cannabis Nurses Network™ (CNN), the Cannabis Nursing: A Paradigm Shift in Healthcare workshop is scheduled for May 7, 2024 in Kansas City, Missouri, at the Kansas City Marriott Downtown.
  • The CSC Spring 2024 conference will be held from May 7 – May 9.
  • As the health care landscape evolves, nurses play a pivotal role in embracing innovative approaches to enhance patient well-being.

Ibogaine By David Dardashti is Offering Women Employment Opportunities

Retrieved on: 
Wednesday, February 28, 2024
Hand, Woman, Trauma, Mental health, Ibogaine, Research, Addiction, Nursing

Ibogaine By David Dardashti has recently added a new team member, Misty Huckabey, a neuroscientist who specializes in compassion studies.

Key Points: 
  • Ibogaine By David Dardashti has recently added a new team member, Misty Huckabey, a neuroscientist who specializes in compassion studies.
  • In the effort to make this happen, our research team is currently in the process of employing two more women to expand on gender related research.
  • Ibogaine By David Dardashti is proud to provide employment opportunities to women, with the primary goal of expanding research to gender based issues involving addiction and trauma.” Ibogaine By David Dardashti prides itself on providing a strong network and support for women in the area.
  • Ibogaine By David Dardashti is committed to increasing awareness and resources for women in addiction by providing employment opportunities and a strong network of support.

Latest Holistic Approach for those Struggling With Chemical Dependency

Retrieved on: 
Friday, February 23, 2024
Neuro, Knowledge, Safety, Function (mathematics), Ibogaine, Prefrontal cortex, Research, Addiction, Cocaine, Frontal lobe, Patient, Brain, Pharmaceutical industry

The effects of this active metabolite begin to peak within a week after treatment, based upon past patients’ reports of improved cognitive functioning.

Key Points: 
  • The effects of this active metabolite begin to peak within a week after treatment, based upon past patients’ reports of improved cognitive functioning.
  • Informative data stems from metabolic data collected before ibogaine treatment and once more in the days to follow.
  • Results from twenty patients indicate smooth stabilization, indicating safety and efficacy of the active metabolite.
  • Thorough monitoring is crucial for sustained success, but the long-term effectiveness of noribogaine necessitates follow-up updates in subsequent months.

Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

Retrieved on: 
Thursday, February 22, 2024
Epilepsy, Pharmacology, DSM-IV codes, Research, GABAA, Drug resistance, 300X, Dizziness, Drug development, PAM, Volunteering, GAERS, Risk, Generalized tonic–clonic seizure, Deficit spending, Rat, Therapy, Ataxia, Memory, MED, Human, Cognition, Patient, Somnolence, Addiction, Partnership, Pharmaceutical industry

MIAMI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the publication of preclinical in vivo data in Drug Development Research highlighting BAER-101’s full suppression of seizure activity using the Genetic Absence Epilepsy Rats from Strasbourg (“GAERS”) model of absence epilepsy.

Key Points: 
  • MIAMI, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced the publication of preclinical in vivo data in Drug Development Research highlighting BAER-101’s full suppression of seizure activity using the Genetic Absence Epilepsy Rats from Strasbourg (“GAERS”) model of absence epilepsy.
  • The publication describes the extent of anti-seizure activity of BAER-101 in the GAERS model, a widely used and translationally relevant animal model.
  • The study demonstrated full suppression of seizure activity with a minimal effective dose (MED) of 0.3 mg/kg.
  • “The preclinical data published in Drug Development Research demonstrate BAER-101’s ability to fully suppress seizures in the GAERS model, a translational animal model for anti-seizure drug development with a documented high predictability of response in humans.

Pinnacle Treatment Centers Hires Dr. Chris Yadron as SVP of Detox, Residential, and Ambulatory Services

Retrieved on: 
Friday, March 1, 2024
Alternative Medicine, Mental Health, Health, Other Health, Managed Care, General Health, Biotechnology, Loyola University, Senior, Chicago school, Research, Mental health, Multimedia, SVP, Addiction, Drug, Loyola University Chicago, Pinnacle, Master, LCPC, University, Knowledge, Outline of counseling, CADC, Hazelden Betty Ford Foundation, Nursing

Pinnacle Treatment Centers, a leading provider of affordable, accessible substance use disorder treatment services, is thrilled to announce the recent hire of Dr. Chris Yadron, Ph.D., LCPC, CADC, as the new Senior Vice President of Detox, Residential, and Ambulatory Services.

Key Points: 
  • Pinnacle Treatment Centers, a leading provider of affordable, accessible substance use disorder treatment services, is thrilled to announce the recent hire of Dr. Chris Yadron, Ph.D., LCPC, CADC, as the new Senior Vice President of Detox, Residential, and Ambulatory Services.
  • View the full release here: https://www.businesswire.com/news/home/20240301160638/en/
    Chris Yadron, Ph.D., LCPC, CADC, SVP of Detox, Residential and Ambulatory Services for Pinnacle Treatment Centers.
  • (Photo: Business Wire)
    With a distinguished record of leadership in the field of Addiction Treatment and Behavioral Health, Dr. Yadron brings invaluable experience and insight to Pinnacle Treatment Centers.
  • "We are thrilled to welcome Dr. Chris Yadron to our team," said Brian Thorn, Chief Operating Officer at Pinnacle Treatment Centers.